1. Home
  2. HCWB vs BOXL Comparison

HCWB vs BOXL Comparison

Compare HCWB & BOXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$1.16

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo Boxlight Corporation

BOXL

Boxlight Corporation

BUY

Current Price

$3.00

Market Cap

3.1M

ML Signal

BUY

Company Overview

Basic Information
Metric
HCWB
BOXL
Founded
2018
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
3.1M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
HCWB
BOXL
Price
$1.16
$3.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 751.6K
33.0K
Earning Date
11-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
$4,099,750.00
★ $25,743,612.00
Revenue This Year
$12,215.61
$0.69
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 26.37
52 Week Low
$0.86
$2.59
52 Week High
$24.42
$62.64

Technical Indicators

Market Signals
Indicator
HCWB
BOXL
Relative Strength Index (RSI) 26.99 34.21
Support Level $1.14 $2.72
Resistance Level $1.73 $5.27
Average True Range (ATR) 0.11 0.48
MACD 0.00 -0.05
Stochastic Oscillator 1.70 9.51

Price Performance

Historical Comparison
HCWB
BOXL

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

About BOXL Boxlight Corporation

Boxlight Corp is a technology company that develops, sells, and services interactive solutions predominantly for the education market but also for the corporate and government sectors. The company currently designs, produces, and distributes interactive technologies, including interactive and non-interactive flat panel displays, LED video walls, media players, classroom audio and campus communication, cameras, and other peripherals for the education market and non-interactive solutions, including flat-panels, LED video walls, and digital signage for the enterprise market. It has three reportable segments - Europe, Middle East and Africa (EMEA), and North and Central America (Americas). The majority of revenue is derived from the sale of education technology products in the EMEA segment.

Share on Social Networks: